Clinical Trials Logo

Filter by:
NCT ID: NCT05548374 Recruiting - Acupuncture Clinical Trials

Acupuncture for Breast Pain

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

This study is conducted to assess the efficacy and safety of acupuncture in moderate to severe cyclic breast pain.

NCT ID: NCT05548348 Recruiting - Clinical trials for Non-small Cell Lung Cancer

First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation

Start date: September 26, 2022
Phase: Phase 2
Study type: Interventional

Furmonertinib, a newly-designed pan-EGFR-TKI with a trifluoroethoxypyridine-based molecule structure, has shown promising clinical efficacy in EGFR Ex19del/L858R/T790M/Ex20ins mutant advanced NSCLC with an acceptable safety profile without new signals from 80mg to 240mg dose level in phase 1-3 clinical trials. Whether EGFR G719X/S768I/L861Q mutation positive advanced NSCLC patients can benefit from first-line furmonertinib 160mg per day has not been reported. This study aims to investigate the efficacy and safety of furmonertinib 160mg per day in EGFR G719X/S768I/L861Q mutant patients under first-line treatment of advanced NSCLC setting.

NCT ID: NCT05548231 Completed - Obesity Clinical Trials

A Study of LY3437943 in Chinese Participants With Obesity Or Overweight

Start date: October 24, 2022
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to learn about the safety and tolerability of LY3437943 when given to Chinese participants with overweight body mass index (BMI) or obesity. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Each enrolled participant will receive injections of LY3437943 or placebo given just under the skin. For each participant, the study will last about 20 weeks excluding screening period and may include up to 20 visits to the study center.

NCT ID: NCT05548153 Completed - Clinical trials for Postoperative Delirium

An Observational Study on the Relationship Between Tear Metabolomics and POD

Start date: August 22, 2022
Phase:
Study type: Observational

To explore the correlation between tear metabolomics and POD. The purpose of this study was to compare the results of tear metabolomics between POD and non-POD elderly patients undergoing abdominal surgery, to clarify the correlation between tear metabolomics and POD, and to find tear markers related to POD.

NCT ID: NCT05547971 Recruiting - Clinical trials for Nasopharyngeal Carcinoma

Development of Intelligent Model for Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on Radio-metabolomics

Start date: September 2022
Phase:
Study type: Observational

This project focuses on the early prediction and diagnosis of radiation-induced brain injury in nasopharyngeal carcinoma patients. Based on the big data of imaging and serum metabonomics samples, combined with the machine learning analysis method, dynamic evolution mode of radio-metabolomics characteristics was analyzed . The potential internal relationship between brain structure and serum metabolic changes was explored, and the individualized prediction model was constructed to screen out the high-risk patients with brain injury after tumor radiotherapy, so as to provide reference for the diagnosis of radiation-induced brain injury caused by tumor. radiotherapy Intelligent diagnosis provides a new theoretical and practical basis.

NCT ID: NCT05547841 Recruiting - Pregnancy Clinical Trials

Normal Reference Value for Echocardiography in Chinese Han Pregnancies

Start date: September 1, 2022
Phase:
Study type: Observational

The First Hospital of China Medical University initiated a multi-center study on the reference range of echocardiography in Chinese Han Pregnancies to determine the reference range of echocardiography in the pregnant population and to promote the clinical application of echocardiography in the pregnant population, thereby offering the value of early evaluation and early diagnosis for cardiac structure and function in the pregnant population.

NCT ID: NCT05547815 Completed - Rabies Clinical Trials

Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine

Start date: November 11, 2019
Phase: Phase 4
Study type: Interventional

Evaluation of immune persistence after rabies vaccination in 150 people.

NCT ID: NCT05547750 Enrolling by invitation - Clinical trials for Nocturnal Leg Cramps

Effect of Vitamin K2 in the Treatment of Nocturnal Leg Cramps in Older Population

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Nocturnal leg cramps (NLCs) are sudden contractions of the leg muscles, usually in the posterior calf muscles at night, affecting sleep quality. Because the precise pathophysiology of NCLs is unclear, different interventions have been proposed. There is conflicting evidence regarding the efficacy of conventional interventions in preventing cramps. Thus, the present study aims to investigate the effects of vitamin K2 for NLCs in a prospective randomized, double-blind, controlled trial.

NCT ID: NCT05547516 Not yet recruiting - Clinical trials for Non-muscle-invasive Bladder Cancer

Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

BL-PDT-RCT
Start date: September 13, 2022
Phase: N/A
Study type: Interventional

This project will conduct a large-sample, multi-center prospective clinical trial to further establish the safety and efficacy of BL-5ALA-PDT in preventing Non-Muscle Invasive Bladder Cancer (NMIBC) recurrence when compared to the usual postoperative perfusion chemotherapy regimen.

NCT ID: NCT05547490 Completed - Psoriasis Clinical Trials

A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis

Start date: October 31, 2022
Phase:
Study type: Observational

The purpose of this study is to achieve a better understanding of clinical characteristics, treatment patterns and clinical outcomes of participants with moderate-to-severe plaque psoriasis (PsO) as well as their unmet medical needs and disease burden in real-world setting in China.